Liminal BioSciences Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Liminal BioSciences Inc with three other companies in this sector in CANADA : Pond Technologies Holdings Inc (2020 sales of 4.80 million Canadian Dollars [US$3.76 million] of which 92% was Nutraceutical Products), VBI Vaccines Inc (1.42 million Canadian Dollars [US$1.11 million] of which 73% was R&D Service revenue), and IBEX Technologies Inc (5.21 million Canadian Dollars [US$4.08 million] ).

Sales Analysis. Sales levels dropped significantly in the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at Liminal BioSciences Inc totalled C$25,000.00 . This is a drop of 95.4% from the C$540,000.00 in sales at the company during the second quarter in 2020. During the first two quarters of 2021, sales totalled C$235,000.00 , which is 85.7% lower than through the first two quarters of 2020. Liminal BioSciences Inc reported sales of C$3.32 million (US$2.60 million) for the year ending December of 2020. This represents a sharp decrease of 32.4% versus 2019, when the company's sales were C$4.90 million. Contributing to the drop in overall sales was the 85.3% decline in Small Mole Cule, from C$34,000.00 to C$5,000.00 . There were also decreases in sales in Plasma Derived Therapeutics (down 45.1% to C$2.60 million) .